Exelixis | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 41.04B 168M 2025-03
Bayer EUR 32.04B 1.49B 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Cytokinetics USD -135372000 121.46M 2024-12
Eisai JPY 873.36B 53.3B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.24B 31.22M 2025-01
Genmab DKK 36.7B 4.78B 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 46.31B 1.81B 2024-12
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Sanofi 77.86B 4.86B 2024-12
Takeda JPY 7.42T 497.52B 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Xencor USD 677.61M 46.22M 2024-12



Exelixis Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.